<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01877122</url>
  </required_header>
  <id_info>
    <org_study_id>MS1-1004</org_study_id>
    <nct_id>NCT01877122</nct_id>
  </id_info>
  <brief_title>Comparative Study of Safety and Efficacy of Heavyweight and Partially Absorbable Mesh in Inguinal Hernia Repair</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samyang Biopharmaceuticals Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samyang Biopharmaceuticals Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proflex® Mesh (partially absorbable mesh, Korea) and Marlex® Mesh (heavyweight mesh) will be
      used for inguinal hernia repair to compare the safety and efficacy (pain score, quality of
      life)of two devices at 3 months follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain score (10-point Visual Analogue Scale)</measure>
    <time_frame>Day90 after operation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hernia, Inguinal</condition>
  <arm_group>
    <arm_group_label>Proflex® Mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Partially absorbable lightweight mesh Intervention: Mesh implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Marlex® Mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Device: Non-absorbable Heavyweight mesh Intervention: Mesh implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Proflex® Mesh Mesh implantation</intervention_name>
    <description>Implantation of mesh in the incision of inguinal area</description>
    <arm_group_label>Proflex® Mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Marlex® Mesh Implant</intervention_name>
    <arm_group_label>Marlex® Mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male patients &gt;=20 years =&lt;85 years old

          2. Patients with Unilateral hernia

          3. Patients without previous operations in lower part of abdomen

          4. Patients capable to understand the explanation about purpose and method of the trial,
             and write an Informed Concent Form

          5. Patients capable to participate during the period of the trial

        Exclusion Criteria:

          1. Previous hernia repair at the same site

          2. Incarcerated hernia

          3. Strangulated hernia

          4. Patients to whom and open surgery cannot be indicated

          5. Previous urological surgery

          6. Immune incompetence of patient: AIDS, vesical fibrosis, etc.

          7. Patients with AIHD or patients who take immunosuppressive drugs

          8. Patients with liver disease (ASL, AST ≥ normal value by more than 3 times)

          9. Patients with kidney disease (creatinine&gt;2.0mg/dL)

         10. Patients on anti-coagulants

         11. Patients with severe systematic disease

         12. Patients with malignant tumor

         13. Patients with infection or with the predicted problem of surgery site healing

         14. Participation in another clinical study within the last 30 days

         15. Patients whose participation is considered inappropriate according to other except
             above mentioned clinical condition
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taeil Son, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eulji Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samyang Biopharmaceuticals</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2013</study_first_submitted>
  <study_first_submitted_qc>June 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2013</study_first_posted>
  <last_update_submitted>June 24, 2015</last_update_submitted>
  <last_update_submitted_qc>June 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

